CS
NVO

Credit Suisse’s Novo Nordisk NVO Stock Holding History

Credit Suisse’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$770K Buy
+6,000
New +$714K ﹤0.01% 2421
2023
Q2 		– Sell
-6,082
Closed -$484K – 3226
2023
Q1 		$484K Sell
6,082
-18,064
-75% -$1.28M ﹤0.01% 2767
2022
Q4 		$1.63M Sell
24,146
-2,980
-11% -$175K ﹤0.01% 1999
2022
Q3 		$1.35M Buy
27,126
+13,272
+96% +$711K ﹤0.01% 2109
2022
Q2 		$772K Buy
+13,854
New +$769K ﹤0.01% 2561
2021
Q4 		– Sell
-4,896
Closed -$235K – 4624
2021
Q3 		$235K Sell
4,896
-253,020
-98% -$12.2M ﹤0.01% 4174
2021
Q2 		$10.8M Buy
257,916
+113,394
+78% +$4.4M 0.01% 1517
2021
Q1 		$4.87M Sell
144,522
-65,432
-31% -$2.33M ﹤0.01% 2088
2020
Q4 		$7.33M Sell
209,954
-642,720
-75% -$22.2M ﹤0.01% 1788
2020
Q3 		$29.6M Buy
852,674
+233,776
+38% +$7.79M 0.02% 829
2020
Q2 		$20.3M Buy
618,898
+183,216
+42% +$5.85M 0.01% 940
2020
Q1 		$13.1M Buy
435,682
+346,142
+387% +$10.3M 0.01% 1043
2019
Q4 		$2.59M Sell
89,540
-215,670
-71% -$5.97M ﹤0.01% 2402
2019
Q3 		$7.89M Buy
305,210
+94,956
+45% +$2.4M 0.01% 1449
2019
Q2 		$5.37M Sell
210,254
-580,488
-73% -$14.3M ﹤0.01% 1711
2019
Q1 		$20.7M Buy
790,742
+386,282
+96% +$9.49M 0.02% 850
2018
Q4 		$9.32M Sell
404,460
-29,568
-7% -$657K 0.01% 1191
2018
Q3 		$10.2M Sell
434,028
-25,906
-6% -$632K 0.01% 1243
2018
Q2 		$10.6M Sell
459,934
-305,212
-40% -$7.25M 0.01% 1203
2018
Q1 		$18.8M Buy
765,146
+468,096
+158% +$12.3M 0.02% 885
2017
Q4 		$7.97M Buy
+297,050
New +$7.55M 0.01% 1431
2017
Q3 		– Sell
-2,122,502
Closed -$45.5M – 4239
2017
Q2 		$45.5M Buy
2,122,502
+544,850
+35% +$11M 0.04% 441
2017
Q1 		$27M Buy
1,577,652
+301,994
+24% +$5.26M 0.02% 676
2016
Q4 		$22.9M Sell
1,275,658
-387,850
-23% -$7.03M 0.02% 740
2016
Q3 		$34.6M Buy
+1,663,508
New +$41.2M 0.03% 588
2016
Q1 		– Sell
-27,212
Closed -$790K – 4196
2015
Q4 		$790K Sell
27,212
-70,474
-72% -$1.95M ﹤0.01% 3016
2015
Q3 		$2.65M Buy
97,686
+17,404
+22% +$493K ﹤0.01% 2051
2015
Q2 		$2.2M Sell
80,282
-126,098
-61% -$3.54M ﹤0.01% 2479
2015
Q1 		$5.51M Buy
206,380
+60,494
+41% +$1.39M 0.01% 1595
2014
Q4 		$3.09M Buy
145,886
+84,360
+137% +$1.88M ﹤0.01% 2159
2014
Q3 		$1.47M Sell
61,526
-9,698
-14% -$223K ﹤0.01% 2728
2014
Q2 		$1.65M Buy
71,224
+7,418
+12% +$164K ﹤0.01% 2884
2014
Q1 		$1.46M Sell
63,806
-13,764
-18% -$293K ﹤0.01% 2789
2013
Q4 		$1.43M Buy
77,570
+39,290
+103% +$685K ﹤0.01% 2972
2013
Q3 		$648K Sell
38,280
-48,010
-56% -$807K ﹤0.01% 3330
2013
Q2 		$1.34M Buy
+86,290
New +$1.44M ﹤0.01% 2573

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse's NVO Position: Q1 2024 in Review

Credit Suisse opened a new position in Novo Nordisk (NVO) in Q1 2024: 6,000 shares worth $770K. The stake represents ﹤0.01% of the portfolio and ranks #2421 among its holdings. This is a return to the name: Credit Suisse previously reported a position in NVO as recently as Q1 2023.

Credit Suisse first reported a position in NVO in Q2 2013 and has held it in 36 quarters since. The position peaked at $45.5M in Q2 2017. 1,745 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Credit Suisse held 6,000 shares of Novo Nordisk worth $770K as of Q1 2024.
  • Novo Nordisk was a new Credit Suisse position in Q1 2024.
  • Novo Nordisk made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2421 holding.
  • Credit Suisse first reported a position in Novo Nordisk in Q2 2013 and has held it in 36 quarters since.
  • Credit Suisse's Novo Nordisk position peaked at $45.5M in Q2 2017.
  • 1,745 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.